Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis – Impact on s-Infliximab and Antidrug-Antibodies. Results from the Danish Rheumatologic Biobank and the Danbio Registry

Research output: Contribution to journalConference abstract in journalResearchpeer-review

View graph of relations
Original languageEnglish
Article number1997
JournalArthritis & Rheumatology
Volume68
Issue numberS10
ISSN1537-2960
Publication statusPublished - 2016

ID: 49831758